US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
In trading on Wednesday, communication services shares fell by 0.7%.U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday.
今天上午美国股市涨跌互现，道琼斯指数周三上涨约20点。
The Dow traded up 0.05% to 42,762.18 while the NASDAQ fell 0.06% to 18,305.30. The S&P 500 also fell, dropping, 0.07% to 5,811.21.
道琼斯指数上涨0.05％，至42,762.18点，而纳斯达克指数下跌0.06％，至18,305.30点。标准普尔500指数也下跌了0.07％，至5,811.21。
Leading and Lagging Sectors
Financials shares jumped by 0.7% on Wednesday.
领先和落后行业
周三，金融股上涨了0.7％。
In trading on Wednesday, communication services shares fell by 0.7%.
在周三的交易中，通信服务股下跌了0.7％。
Top Headline
热门标题
On Wednesday, Abbott Laboratories (NYSE:ABT) reported better-than-expected third-quarter results.
周三，雅培实验室（纽约证券交易所代码：ABT）公布的第三季度业绩好于预期。
The company posted sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20.
该公司公布的销售额为106.4亿美元，同比增长4.9％，超过了预期的105.5亿美元。雅培调整后的摊薄后每股收益为1.21美元，超过了分析师预期的1.20美元。
Equities Trading UP
股票交易上涨
- 180 Life Sciences Corp (NASDAQ:ATNF) shares shot up 668% to $11.73. 180 Life Sciences interim CEO said that the company is planning to enter the online gaming industry with its newly acquired gaming technology platform.
- Shares of Santech Holdings Limited (NASDAQ:STEC) got a boost, surging 592% to $2.50.
- Versus Systems Inc. (NASDAQ:VS) shares were also up, gaining 422% to $5.90 after the company announced a $2.5 million investment and licensing agreement with ASPIS.
- 180生命科学公司（纳斯达克股票代码：ATNF）股价飙升668％，至11.73美元。180生命科学临时首席执行官表示，该公司计划通过其新收购的游戏技术平台进入在线游戏行业。
- Santech Holdings Limited（纳斯达克股票代码：STEC）的股价上涨了592％，至2.50美元。
- Versus Systems Inc.（纳斯达克股票代码：VS）的股价也上涨了422％，至5.90美元，此前该公司宣布与ASPIS签订了250万美元的投资和许可协议。
Equities Trading DOWN
股票交易下跌
- Bright Minds Biosciences Inc (NASDAQ:DRUG) shares dropped 39% to $23.39. Firefly Neuroscience collaborated with Bright Minds Biosciences to analyze the data from its positive Phase 1 study using its Artificial Intelligence.
- Shares of Silvaco Group, Inc. (NASDAQ:SVCO) were down 28% to $7.94 after the company reported a decline in orders from Asia during third quarter and cut its FY24 revenue outlook.
- Zapata Computing Holdings Inc. (NASDAQ:ZPTA) was down, falling 26% to $0.09.
- Bright Minds Biosciences Inc（纳斯达克股票代码：DRUG）股价下跌39％，至23.Firefly Neuroscience与Bright Minds Biosciences合作，使用其人工智能分析了其积极的1期研究的数据。
- Silvaco集团公司（纳斯达克股票代码：SVCO）的股价下跌28％，至7.94美元，此前该公司报告第三季度来自亚洲的订单下降并下调了24财年的收入展望。
- 扎帕塔计算机控股公司（纳斯达克股票代码：ZPTA）下跌26％，至0.09美元。
Commodities
In commodity news, oil traded down 0.1% to $70.53 while gold traded up 0.8% at $2,700.00.
大宗商品
在大宗商品新闻方面，石油价格下跌0.1％，至70.53美元，而黄金上涨0.8％，至2700.00美元。
Silver traded up 1.8% to $32.325 on Wednesday, while copper rose 0.8% to $4.3725.
周三，白银上涨1.8％，至32.325美元，铜价上涨0.8％，至4.3725美元。
Euro zone
欧元区
European shares were mixed today. The eurozone's STOXX 600 slipped 0.2%, Germany's DAX slipped 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 gained 0.9%.
今天欧洲股市涨跌互现。欧元区斯托克600指数下跌0.2％，德国DAX指数下跌0.2％，法国CAC 40指数下跌0.5％。西班牙的IBEX 35指数上涨0.4％，而伦敦富时100指数上涨0.9％。
Asia Pacific Markets
亚太市场
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 1.83%, Hong Kong's Hang Seng Index falling 0.16%, China's Shanghai Composite Index gaining 0.05% and India's BSE Sensex falling 0.39%.
周三亚洲市场收盘大多走低，日本日经225指数下跌1.83％，香港恒生指数下跌0.16％，中国上证综合指数上涨0.05％，印度BSE Sensex下跌0.39％。
Economics
经济学
- U.S. mortgage applications fell by 17% from the previous week during the second week of October.
- Export prices in the U.S. declined by 0.7% month-over-month in September, exceeding market estimates of a 0.4% fall.
- Import prices declined by 0.4% from the previous month in September.
- 在10月的第二周，美国抵押贷款申请较前一周下降了17％。
- 美国9月份的出口价格同比下降0.7％，超过了市场预期的0.4％的跌幅。
- 9月份的进口价格比上个月下降了0.4％。
Now Read This:
现在读这个：
- Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
- 吉姆·克莱默：“我们需要更多的铀”，推荐这只股票；诺和诺德对大型制药公司的竞争对手说 “不相提并论”
